Health and Healthcare

BioMarin : BMRN

All BioMarin Articles

169 Articles

Chris Lange | Mar 13, 2016 at 10:35 AM EDT

5 Key FDA Decisions Expected in March

24/7 Wall St. has collected three big FDA decisions coming up in March and added some color, along with the…

Lee Jackson | Mar 8, 2016 at 9:25 AM EST

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

With biotechs still way out of favor, investors need to be cautious, as often these companies are dependent on binary…

Jon C. Ogg | Feb 29, 2016 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More

The top analyst upgrades, downgrades and initiations seen on Monday, February 29, include Huntington Bancshares, Nucor, Orexigen Therapeutics, SanDisk, Square…

Chris Lange | Feb 28, 2016 at 10:45 AM EST

How Analysts Changed Views on BioMarin After Earnings

Investors really took to BioMarin Pharmaceuticals stock and there was a favorable jump after the fourth-quarter earnings report.

Chris Lange | Jan 20, 2016 at 11:45 AM EST

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…

Jon C. Ogg | Jan 20, 2016 at 8:55 AM EST

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Wednesday's top analyst calls include AMD, Amazon.com, Celgene, Comerica, Fortinet, Gilead Sciences, Lennar, Netflix, Voya and Wayfair.

Chris Lange | Jan 15, 2016 at 10:05 AM EST

Why Sarepta Therapeutics Is Cratering

Sarepta Therapeutics plunged early on Friday as the result of a failed clinical trial by BioMarin Pharmaceutical.

Chris Lange | Jan 2, 2016 at 10:15 AM EST

4 Top FDA Decisions Expected in Q1

24/7 Wall St. has collected four companies big FDA decisions coming up in the first quarter of 2016 and added…

Lee Jackson | Dec 2, 2015 at 10:20 AM EST

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

A new Jefferies research report focuses on some biotech and specialty pharmaceutical stocks that have had some headline and clinical…

Jon C. Ogg | Nov 18, 2015 at 8:40 AM EST

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

Wednesday's top analyst upgrades, downgrades and initiations include Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club and Perrigo.

Lee Jackson | Nov 16, 2015 at 8:40 AM EST

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

This week the Jefferies analysts are positive on companies that took a shot price-wise last week and may be offering…

Jon C. Ogg | Nov 15, 2015 at 9:41 AM EST

15 Fresh Analyst Stock Picks Called to Rise 50% to 100%

24/7 Wall St. tracked 15 fresh analyst calls in this past week alone in which analysts were calling for upside…

Jon C. Ogg | Nov 13, 2015 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Abbott, BioMarin, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower, Yelp and More

Friday's top analyst upgrades, downgrades and initiations include Abbott Labs, BioMarin Pharmaceutical, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower and…

Lee Jackson | Oct 7, 2015 at 8:40 AM EDT

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility…

Jon C. Ogg | Sep 30, 2015 at 2:40 PM EDT

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

A report on Wednesday from Janney Capital Markets has targeted several iotech bcompanies it believes are now grossly oversold.

1 … 5 6 7 8 9 … 12

BioMarin : BMRN

All BioMarin Articles

5 Key FDA Decisions Expected in March

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More

How Analysts Changed Views on BioMarin After Earnings

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Why Sarepta Therapeutics Is Cratering

4 Top FDA Decisions Expected in Q1

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

15 Fresh Analyst Stock Picks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: Abbott, BioMarin, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower, Yelp and More

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

BioMarin : BMRN

All BioMarin Articles

5 Key FDA Decisions Expected in March

Top Biotech Stocks Dominate Jefferies Growth Stocks to Buy This Week

Top Analyst Upgrades and Downgrades: Huntington Bancshares, Nucor, Orexigen, SanDisk, Square, VIVUS and Many More

How Analysts Changed Views on BioMarin After Earnings

Despite Market and Sector Risks, Why Credit Suisse Now Loves Top Biotechs

Top Analyst Upgrades and Downgrades: AMD, Amazon, Celgene, Comerica, Fortinet, Gilead, Lennar, Netflix, Voya, Wayfair and Many More

Why Sarepta Therapeutics Is Cratering

4 Top FDA Decisions Expected in Q1

4 Top Jefferies Biotech and Specialty Pharma Growth Stocks to Buy Now

Top Analyst Upgrades and Downgrades: Apple, Bluebird, Exxon Mobil, Kinder Morgan, Kinross Gold, Lending Club, Perrigo and Many More

Hot Biotech Stocks Highlight Jefferies Top Growth Stocks to Buy This Week

15 Fresh Analyst Stock Picks Called to Rise 50% to 100%

Top Analyst Upgrades and Downgrades: Abbott, BioMarin, CBS, Cisco, GameStop, Petrobras, Sirius XM, SunPower, Yelp and More

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

Technician Picks Oversold Biotechs for Large Potential Trading Bounces

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Concentration Risk High as Top Two Stocks Steer U.S. Communication Services ETF Performance

Amazon and Tesla Drive One-Third of FDIS as U.S. Spending Surges Despite Recession-Level Sentiment

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s